Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Genedrive Share Price (GDR)



Share Price Information for Genedrive (GDR)


Share Price: 36.00Bid: 35.00Ask: 37.00Change: 0.00 (0.00%)No Movement on Genedrive
Spread: 2.00Spread as %: 5.71%Open: 36.00High: 36.00Low: 36.00Yesterday’s Close: 36.00

Genedrive Plc Ord 1.5P

Genedrive is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
36.00

Share Price SpacerBid
35.00

Share Price SpacerAsk
37.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
1,500

Share Price SpacerOpen
36.00

Share Price SpacerHigh
36.00

Share Price SpacerLow
36.00

Share Price SpacerClose
36.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 18.69m £6.73m 1,000

52 Week High 60.00 52 Week High Date 3-FEB-2017
52 Week Low 32.00 52 Week Low Date 4-SEP-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1 1,500 0 -1.032 -34.90 0.00 0.00


London South East Users info for Genedrive


Users who watch GDR also watch: Plant Impact, Redcentric, Ent. One Di, Costain, Accesso Tech, Xlmedia, Renew Holdings

Users who hold GDR also hold: Foresight Vct P, Dixons Carpho, Barclays


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

12-Dec-17
10:36:58
35.02
1,500
Sell* 
35.00
37.00
525.30
Trade Type:
Ordinary

11-Dec-17
14:19:39
35.02
1,500
Sell* 
35.00
37.00
525.30
Trade Type:
Ordinary

11-Dec-17
09:36:28
35.02
6,130
Sell* 
35.00
37.00
2,147
Trade Type:
Ordinary




View more Genedrive trades >>

Directors Deals for Genedrive (GDR)
Trade DateActionNotifierPriceCurrencyAmountHolding
There is currently no Directors Deals information for Genedrive
View more Genedrive directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
27 Nov '17Ctw2014RE: RNS36.00No Opinion
Thanks for your contribution B1979. However, I quote from an email received from Genedrive Plc today:
"The ex-works cost (before shipping and distribution margin) of the Cepheid GeneXpert platform required to run their HCV assay is a minimum cost of $17,000 USD). It also requires regular maintenance and servicing which costs an additional $2000 per year (after 1 year warranty period). The system requires a continuous power supply and has a large footprint making it unsuitable for use… Read More
26 Nov '17B1979RE: RNS36.00No Opinion
The only portable molecular HCV test- I think that depends on how you define portbale. Cepheid are the kings of pointof care testing and they have a very well characterized molecular HCV test- as well as a portfolio of dozens of other assays for clinical diagnostics. I don't see a compelling reason to go for the GD product personally.
As for the plasma separation device, it will likely mimic the device developed by Liu et al at UPenn (see pubmed central article PMCID: PMC4729584), GD will need… Read More
25 Nov '17Ctw2014RNS36.00No Opinion
Yes, we are effectively being paid to develop a centrifuge free plasma separation device which will have a wide range of applications whilst at the same time supporting sales of the HCV kit. I am no expert but I was hugely encouraged by email confirmation from the company that Genedrive is the only portable point of care molecular test (thus complying with WHO guidelines) available for HCV. There are other portable rapid point of care tests available for HCV but these are not molecular and… Read More
22 Nov '17TroytoTiberRE: RNS37.50Strong Buy
Makes a nice contribution to running costs ctw!

Be good to know if anyone on this board has found any expert opinion on genedrive hcv tests and portable device post the European approval. Fairly sure that Sysmex would not have signed 2 distribution deals had they not been very confident but then again they don't have a lot of skin in the game if it doesn't sell as they haven't incurred any costs. Which reminds me that Id still like to know why genedrive retained manufacturing risk in… Read More
21 Nov '17Ctw2014RNS37.50No Opinion
Good to see this free development funding confirmed.
14 Nov '17jupiternmarsDavid Budd with Andrew Scott37.50No Opinion

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Genedrive (GDR) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.